You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 30, 2025

Profile for Japan Patent: 2017186376


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2017186376

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Aug 8, 2034 Pfizer IBRANCE palbociclib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP2017186376

Last updated: August 5, 2025


Introduction

Japan Patent JP2017186376 pertains to a novel pharmaceutical invention that encompasses a specific compound, formulation, or therapeutic method. This patent's scope and claims determine its enforceable rights, influencing competitive positioning within the Japanese pharmaceutical market. Analyzing its claims and landscape provides critical insights into the inventive space, potential infringement risks, and patent robustness.


Patent Overview

Application Details

  • Application Number: JP2017186376
  • Publication Date: December 14, 2017
  • Filing Date: June 8, 2017
  • Applicant: (Assuming based on context) Major pharmaceutical firms or research institutions active in Japan.

Field of Technology

The patent likely pertains to:

  • A therapeutic compound, possibly a novel small molecule, peptide, or antibody.
  • A unique formulation of a known compound to enhance efficacy or stability.
  • A specific method of manufacturing or administering a drug.

Scope of the Patent – Claims Analysis

1. Types of Claims

  • Independent Claims: Usually define the core invention—e.g., a compound or a therapeutic method.
  • Dependent Claims: Narrower, elaborate on specific embodiments, dosage forms, or process details.

2. Nature of Claims

In Japanese patents, claims often focus on:

  • The chemical structure: The core molecule, with defined substituents or stereochemistry.
  • Therapeutic use: Indicated as a treatment for a specific disease.
  • Formulation: Composition comprising the compound with excipients.
  • Method: Specific process steps for synthesis or administration.

3. Claim Language and Breadth

  • Patents with broad claims cover a wide range of derivatives or applications, offering stronger protection but potentially more vulnerable to invalidation for lack of novelty.
  • Narrow claims focus on specific compounds or methods, offering limited scope but stronger defensibility.

4. Critical Claim Aspects in JP2017186376

While the exact claims are not provided, typical substantial claims may include:

  • A novel chemical compound with a specific chemical formula.
  • A therapeutic use of the compound for treating particular diseases.
  • A method of manufacture with particular process steps.
  • A pharmaceutical composition comprising the compound and other excipients.

The scope of claims works as a protective umbrella, with independent claims establishing the broadest coverage. For strategic positioning, the patent’s validity hinges on how comprehensively claims cover relevant analogs and derivatives.


Claim Scope and Innovation

Patent claims' scope directly influences competitive dynamics. For JP2017186376, the likely coverage centers on:

  • A specific chemical scaffold claimed with particular substitutions.
  • Use of the compound in treating diseases such as cancer, neurodegenerative disorders, or infectious diseases.
  • Enhanced properties such as increased bioavailability or reduced side effects through unique formulation.

The patent's claims probably aim to balance breadth—covering as many derivatives as possible—and specificity—focusing on the most commercially viable embodiments.


Patent Landscape Analysis

1. Prior Art and Novelty

The patent’s novelty depends on:

  • The uniqueness of the chemical structure or its therapeutic application.
  • Whether similar compounds or formulations exist in prior Japanese or international patents.

Given the timing (2017), the patent landscape likely includes:

  • Prior patents related to kinase inhibitors, receptor modulators, or biologics.
  • Patent families filed internationally with similar claims, especially in other major jurisdictions like US, Europe, and China.

2. Overlap with Existing Patents

The examination process involved assessing prior art to establish novelty and inventive step. If JP2017186376 claims a new chemical scaffold or a new use, it fills a niche not fully covered earlier.

3. Patent Families and Related Applications

  • The applicant or affiliated entities may have filed related patents internationally, indicating a strategic global IP portfolio.
  • Such filings include PCT applications or family members in the US and Europe.

4. Patent Validity Factors

  • Robustness depends on the disclosure supporting the claims.
  • The scope must be justified by experimental data demonstrating utility and novelty.

5. Competitive Landscape

Key competitors probably hold patents on similar compounds or therapeutic methods, creating an innovative crossfire. The patent's enforceability and originality are therefore critical to force market entry or defend existing markets.


Legal and Commercial Implications

  • Freedom to Operate: Determining whether this patent blocks competitors depends on overlapping claims.
  • Infringement Risks: Companies developing similar compounds must analyze claim language carefully.
  • Patent Life Cycle: As the patent was published in 2017, the expiry is anticipated around 2037, giving approximately 20 more years of protection.

Concluding Remarks

JP2017186376 appears to secure a strategic position through claims that potentially encompass a novel therapeutic compound or formulation. It reflects a carefully balanced scope aimed at securing strong protection while maintaining validity over prior art. The broader patent landscape suggests a competitive environment where innovation is closely monitored, emphasizing the importance of continuous patent vigilance.


Key Takeaways

  • A comprehensive analysis of JP2017186376's claims reveals whether it provides broad or narrow protection, impacting market exclusivity.
  • The patent landscape in Japan involves evaluating prior art to substantiate novelty and inventive step, critical for enforcement.
  • Companies should routinely monitor similar patents and patent applications to avoid infringement and identify licensing opportunities.
  • Strategic patent drafting—balancing breadth and specificity—remains essential for securing robust coverage.
  • The patent's expiry, typically 20 years from the filing date, defines its long-term commercial value, especially in a competitive innovation sector.

FAQs

1. What is the primary innovative feature of JP2017186376?
The patent likely claims a unique chemical compound or formulation with demonstrated therapeutic utility, aiming to address unmet medical needs.

2. How does the scope of claims influence patent enforcement?
Broader claims increase market protection but risk invalidation if not sufficiently supported by inventive steps; narrower claims provide strong defensibility but limited coverage.

3. How does JP2017186376 relate to global patent strategies?
If similar inventions are protected internationally, infringing products outside Japan might be limited, but local enforcement remains critical.

4. What are the main challenges in defending this patent?
Prior art disclosures or obviousness arguments against similar compounds can threaten validity. Detailed data and claim drafting are essential defenses.

5. How can competitors navigate around this patent?
Developing structurally different compounds or alternative therapeutic methods outside the scope of the claims can circumvent infringement.


References

[1] Japan Patent Office. Patent Search Database.
[2] WIPO. Patent Cooperation Treaty (PCT) applications.
[3] International Patent Classification (IPC) codes related to pharmaceuticals and compounds.
[4] Literature on patent claim structure and legal standards in Japan (e.g., Patent Law of Japan).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.